Publications for EBV-MS

• Advancing Multiple Sclerosis Research: Highlights from the Neuro-SysMed Symposium 2025
• EBV-MS Consortium Showcases Cutting-Edge Research on Epstein-Barr Virus and Multiple Sclerosis at ECTRIMS 2025
• Breaking Ground on EBV and MS: Highlights from ECTRIMS 2025 Educational Session
• Meet Our new EBV-MS Partner: The Cyprus Institute of Neurology and Genetics (CING)
• Meeting with the Scientific Advisory Board of the EBV-MS Project
• On the role of EBV in MS - Educational Session at ECTRIMS 2025
• Epstein-Barr Virus and Its Role in Multiple Sclerosis: A Growing Area of Research

• Research Data Management in EBV-MS

   

• The EBV-MS Annual Consortium Meeting 2024: Reflecting on Progress
• ECTRIMS 2024
• Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design

• How Current Research Shapes the Future of MS Care: A Recap of Our Successful Symposium

   

For 30 år siden fantes ingen behandling for sykdommen Sara Louise fikk som 17-åring - Newspaper BA ^{_{Feb 2025}}

Nytt forskningsprosjekt om kyssesykevirus og MS - Novartins Medhub _{^{Aug 2025}}

Investigating the Cause of Multiple Sclerosis - ft. Dr. Marianna Cortese - Podcast in Offspring Magazine _{^{Feb 2025}}

EBV-MS: Unveiling the relationship between Epstein-Barr virus and multiple sclerosis - el-lipse _{^{April 2025}}

The new Honorary Doctor hopes to create a vaccine against MS - UiB _{^{Aug 2025}}

How Does EBV Cause MS -- Hit and Run or Chronic Driver? ^{Nov 2025}

Studie: Oppsiktsvekkende om MS-medisin - Newspaper Dagbladet _{^{Jan 2025}}

Kan hiv-medisin hjelpe mot MS? - Forskning.no _{^{Feb 2024}}

MS i Norge - Sykdommen, årsakene og dagens og fremtidens behandling - YouTube _²⁰²⁴

Gir nytt håp til MS-syke - Magazine KK _{^{April 2024}}

MS: Et av verdens vanligste virus kan gi svar på gåten bak den nevrologiske sykdommen - HealthTalk _{^{March 2024}}

Kan HIV-medisin virke på MS-pasienter? Norske forskere vil finne det ut - Health Talk _{^{Oct 2024}}

Case Study Reports Positive Impact of Antiviral Therapy Tenofovir in MS, Warranting Further Research - NeurologyLive _{^{Feb 2024}}

Scientists want to tackle multiple sclerosis by treating the kissing virus - The Economist _{^{Feb 2024}}

5 quick questions about Epstein-Barr-virus and Multiple Sclerosis -UiB _{^{May 2024}}

Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in people with MS? - The Conversation _{^{June 2024}}

Risikoen for å få MS økte med 32 ganger etter en EBV-infeksjon - Nevrologisk Tidsskrift Aug 2023

Leder internasjonalt forskningsprosjekt: – Vi er nærmere en løsning på MS-gåten enn noen gang - Dagens Medisin _{^{Sept 2023}}

Norske forskere leder EU-prosjekt om MS og kyssesykevirus - MEDWATCH Sept 2023

Fantastisk forskningsmiddel-dryss over MS-feltet - Dagens Medisin _{^{Des 2023}}

Trekker frem en nedtur og to oppturer på MS-feltet i 2023 - Dagens Medisin _{^{Des 2023}}

Targeting Epstein-Barr virus to treat and prevent MS - UiB _{^{Sept 2023}}

Veroni C, Carbone F, Ricci D, et al (2026). Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy. Journal of Autoimmunity, Volume 159. 

Olivia G. Thomas, Urszula Rykaczewska, Marina Galesic et al (Jan 2026). Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis. Cell 189, 585-602 

Mechelli R, Umeton R, Bellucci G, et al. (2025). A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 122(14), e2418783122.